
|Articles|February 15, 2007
Orphan status given to two drugs
Jersey City, NJ-The FDA has granted orphan drug designation to two investigational therapeutics of Lux Biosciences, a privately held biotechnical company specializing in treatments for ophthalmic diseases.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement

















